|
Tabla 2: Comparación entre sujetos con prurito estratificado por intensidad. |
|||
|
|
EVA ≤ 6 (n = 65) n (%) |
EVA > 6 (n = 34) n (%) |
p |
|
Características generales |
|||
|
Edad |
42.4 ± 15.1 |
49.7 ± 13.8 |
0.021 |
|
Femenino |
23 (35.4) |
16 (47.1) |
0.250 |
|
Índice de masa corporal |
23.8 (4.1) |
25.9 (4.2) |
0.019 |
|
Tiempo en ERC |
24.2 (36.3) |
39.6 (49.7) |
0.083 |
|
Hemodiálisis |
45 (69.2) |
20 (58.8) |
0.300 |
|
Tiempo en TTR |
13.5 (24.8) |
14.1 (18.6) |
0.900 |
|
Tratamiento de prurito |
|||
|
Antihistamínicos |
0 (0.0) |
2 (5.9) |
0.048 |
|
Emolientes |
28 (43.1) |
21 (61.8) |
0.077 |
|
Gabapentina |
0 (0.0) |
1 (2.9) |
0.160 |
|
Estudios de laboratorio |
|||
|
Urea, mg/dL |
170.9 ± 87.1 |
173.1 ± 71.1 |
0.450 |
|
Creatinina, mg/dL |
11.7 ± 5.8 |
11.5 ± 5.0 |
0.900 |
|
Sodio, mEq/L |
133.6 ± 15.6 |
135.6 ± 2.9 |
0.910 |
|
Potasio, mEq/L |
5.1 ± 1.4 |
4.8 ± 1.1 |
0.470 |
|
Cloro, mEq/L |
101.1 ± 5.2 |
100.3 ± 5.8 |
0.350 |
|
Fósforo, mg/dL |
5.9 ± 2.0 |
6.3 ± 2.8 |
0.480 |
|
Calcio, mg/dL |
7.9 ± 1.0 |
8.0 ± 1.5 |
0.450 |
|
Parathormona, ng/dL |
844.4 ± 781.8 |
877.8 ± 439.1 |
0.800 |
|
ERC = enfermedad renal crónica, TTR = terapia de reemplazo renal. |
|||